Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study, International Journal of Chronic Obstructive Pulmonary Disease, February 2014, Taylor & Francis,
DOI: 10.2147/copd.s51592.
You can read the full text:



The following have contributed to this page